Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants

Transplantation

Volumn 87, Issue 1, 2009, Pages 16-23

  Boisgérault, Florence ^a   Liu, Ying ^b   Anosova, Nathalie ^a   Dana, Reza ^b   Benichou, Gilles ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Corneal transplantation; Cytokines; Indirect allorecognition; Skin graft; T cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN; CYTOKINE; HISTOCOMPATIBILITY ANTIGEN;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TRANSPLANTATION; CONTROLLED STUDY; CORNEA TRANSPLANTATION; FEMALE; GRAFT REJECTION; IMMUNOGENICITY; LYMPHOCYTE DIFFERENTIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; T LYMPHOCYTE ACTIVATION; ALLOTRANSPLANTATION; ANIMAL; AUTOIMMUNITY; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; SKIN TRANSPLANTATION;

ANIMALS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CORNEAL TRANSPLANTATION; CYTOKINES; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; MICE; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 58949097413     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318191b38b     Document Type: Article

References (47)

1. Lechler RI, Lombardi G, Batchelor JR, et al. The molecular basis of alloreactivity. Immunol Today 1990; 11: 83.
2. Lindahl KF, Wilson DB. Histocompatibility antigen-activated cytotoxic T lymphocytes. I. Estimates of the absolute frequency of killer cells generated in vitro. J Exp Med 1977; 145: 500.
3. Suchin EJ, Langmuir PB, Palmer E, et al. Quantifying the frequency of alloreactive T cells in vivo: New answers to an old question. J Immunol 2001; 166: 973.
4. Benichou G, Takizawa PA, Olson CA, et al. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175: 305.
5. Fangmann J, Dalchau R, Sawyer GJ, et al. T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection. Eur J Immunol 1992; 22: 1525.
6. Liu Z, Colovai AI, Tugulea S, et al. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 1996; 98: 1150.
7. Lee RS, Grusby MJ, Glimcher LH, et al. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med 1994; 179: 865.
8. Valujskikh A, Matesic D, Gilliam A, et al. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. J Clin Invest 1998; 101: 1398.
9. Braun MY, Grandjean I, Feunou P, et al. Acute rejection in the absence of cognate recognition of allograft by T cells. J Immunol 2001; 166: 4879.
10. Jones ND, Turvey SE, Van Maurik A, et al. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol 2001; 166: 2824.
11. Joo CK, Pepose JS, Stuart PM. T-cell mediated responses in a murine model of orthotopic corneal transplantation. Invest Ophthalmol Vis Sci 1995; 36: 1530.
12. Billingham RE, Medawar PD. The technique of free skin grafting in mammals. J Exp Biol 1951; 28: 385.
13. Benichou G, Valujskikh A, Heeger PS. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999; 162: 352.
14. Popov IA, Fedoseyeva EV, Orr PL, et al. Direct evidence for in vivo induction of CD8+ cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation. Transplantation 1995; 60: 1621.
15. Dalloul AH, Chmouzis E, Ngo K, et al. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J Immunol 1996; 156: 4114.
16. Krieger NR, Yin DP, Fathman CG. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 1996; 184: 2013.
17. Valujskikh A, Heeger PS. CD4+ T cells responsive through the indirect pathway can mediate skin graft rejection in the absence of interferon-gamma. Transplantation 2000; 69: 1016.
18. Williams MA, TrambleyJ, Ha J, et al. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J Immunol 2000; 165: 6849.
19. Haskova Z, Usiu N, Pepose JS, et al. CD4+ T cells are critical for corneal, but not skin, allograft rejection. Transplantation 2000; 69: 483.
20. Krensky AM, Clayberger C. The nature of allorecognition. Curr Opin Nephrol Hypertens 1993; 2: 898.
21. Lechler R, Lombardi G. Structural aspects of allorecognition. Curr Opin Immunol 1991; 3: 715.
22. Benichou G, Fedoseyeva E, Lehmann PV, et al. Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation. J Immunol 1994; 153:938.
23. Gould DS, Auchincloss H Jr. Direct and indirect recognition: The role of MHC antigens in graft rejection. Immunol Today 1999; 20: 77.
24. Sayegh MH, Watschinger B, Carpenter CB. Mechanisms of T cell recognition of alloantigen. The role of peptides. Transplantation 1994; 57: 1295.
25. Suciu-Foca N, Liu Z, Harris PE, et al. Indirect recognition of native HLA alloantigens and B-cell help. Transplant Proc 1995; 27: 455.
26. Goulmy E. Human minor histocompatibility antigens. Curr Opin Immunol 1996; 8: 75.
27. Chicz RM, Urban RG, Lane WS, et al. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992; 358: 764.
28. Sano Y, Ksander BR, Streilein JW. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice. Transpl Immunol 1996; 4: 53.
29. Boisgerault F, Liu Y, Anosova N, et al. Role of CD4 + and CD8 + T cells in allorecognition: Lessons from corneal transplantation. J Immunol 2001; 167: 1891.
30. Whitsett CF, Stulting RD. The distribution of HLA antigens on human corneal tissue. Invest Ophthalmol Vis Sci 1984; 25: 519.
31. Bartlett ST, Jennings AS, Yu C, et al. Influence of culturing on the survival of major histocompatibility complex-compatible and -incompatible thyroid grafts in rats. J Exp Med 1983; 157: 348.
32. Hegde S, Niederkorn JY. The role of cytotoxic T lymphocytes in corneal allograft rejection. Invest Ophthalmol Vis Sci 2000; 41: 3341.
33. Sano Y, Ksander BR, Streilein JW. Analysis of primed donor-specific T cells in recipient mice bearing orthotopic corneal allografts. Transplantation 2000; 70: 1302.
34. Peeler J, Niederkorn J, Matoba A. Corneal allografts induce cytotoxic T cell but not delayed hypersensitivity responses in mice. Invest Ophthalmol Vis Sci 1985; 26: 1516.
35. Smith CM, Wilson NS, Waithman J, et al. Cognate CD4( + ) T cell licensing of dendritic cells in CD8(+) T cell immunity. Nat Immunol 2004; 5: 1143.
36. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982; 155: 31.
37. Larsen CP, Morris PJ, Austyn JM. Donor dendritic leukocytes migrate from cardiac allografts into recipients' spleens. Transplant Proc 1990; 22: 1943.
38. Streilein JW, Toews GB, Bergstresser PR. Corneal allografts fail to express Ia antigens. Nature 1979; 282: 326.
39. Liu Y, Hamrah P, Zhang Q, et al. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med 2002; 195: 259.
40. Hamrah P, Liu Y, Zhang Q, et al. The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci 2003; 44: 581.
41. Sosnova M, Bradl M, Forrester JV. CD34+ corneal stromal cells are bone marrow-derived and express hemopoietic stem cell markers. Stem Cells 2005; 23: 507.
42. Yamagami S, Usui T, Amano S, et al. Bone marrow-derived cells in mouse and human cornea. Cornea 2005; 24(8 suppl): S71.
43. Streilein JW. New thoughts on the immunology of corneal transplantation. Eye 2003; 17: 943.
44. Niederkorn JY. The immune privilege of corneal grafts. J Leukoc Biol 2003; 74: 167.
45. Huq S, Liu Y, Benichou G, et al. Relevance of the direct pathway of sensitization in corneal transplantation is dictated by the graft bed mi-croenvironment. J Immunol 2004; 173: 4464.
46. Matoba AY, Peeler JS, Niederkorn JY. T cell subsets in the immune rejection of murine heterotopic corneal allografts. Invest Ophthalmol Vis Sci 1986; 27: 1244.
47. Ross J, Callanan D, Kunz H, et al. Evidence that the fate of class II-disparate corneal grafts is determined by the timing of class II expression. Transplantation 1991; 51: 532.